Hemocoagulase Bothrops Atrox for Injection 0.5 unit

Selling Units:	Piece/Pieces

Background:

Hemocoagulase Bothrops Atrox for Injection is a medication derived from the venom of the snake Bothrops atrox. This pharmaceutical product has gained recognition in the medical field for its unique hemostatic properties, making it a valuable tool in quickly stop bleeding in various clinical situations. The use of snake venom for medicinal purposes is rooted in traditional medicine practices, and the development of Hemocoagulase Bothrops Atrox as an injectable form has brought about a more controlled and standardized approach to its application.

The primary mechanism of action of Hemocoagulase Bothrops Atrox lies in its ability to influence the blood Coagulation System. Coagulation is a complex physiological process involving a series of intricate steps that lead to the formation of a stable blood clot. The venom-derived substance in this injection acts as a hemostatic agent by promoting the conversion of fibrinogen to fibrin, the key component of blood clots. This process is vital in preventing and controlling excessive bleeding, particularly in situations where normal Hemostasis is compromised.

One of the notable applications of Hemocoagulase Bothrops Atrox for Injection is in surgical procedures where managing blood loss is critical. Surgeons often utilize this medication to enhance hemostasis during various surgeries, including cardiovascular, orthopedic, and abdominal procedures. By promoting the formation of stable blood clots, Hemocoagulase Bothrops Atrox contributes to reducing bleeding during and after surgery, facilitating better visualization for the surgical team and improving patient outcomes.

Hemostatic Products-Hemocoagulase Bothrops Atrox for Injection:

Intravenous, intramuscular, or subcutaneous, can also be used locally. General bleeding: adults 1~2 units; Children 0.3~0.5 units. Emergency bleeding: immediately intravenously inject 0.25~0.5 units, while intramuscularly injecting 1 unit. All kinds of surgical operations: intramuscular injection of 1 unit the day before surgery, intramuscular injection of 1 unit 1 hour before surgery, intravenous injection of 1 unit 15 minutes before surgery, 3 days after surgery, intramuscular injection of 1 unit per day; Hemoptysis: 1 unit subcutaneously every 12 hours, if necessary, add 1 unit intravenously at the beginning, preferably 10ml of 0.9% NaCl solution, mixed injection; Abnormal bleeding: Doubling the dose，intramuscular injection of 1 unit at an interval of 6 hours until the bleeding stops completely.